|By PR Newswire||
|September 17, 2013 07:00 AM EDT||
ESTERO, Fla., Sept. 17, 2013 /PRNewswire/ -- Vision Pharma, LLC has initiated a civil action against Sunrise Pharmaceutical, Inc. of Rahway, New Jersey in U.S. District Court for the District of New Jersey, Trenton Division. The nine-count lawsuit seeks to recover at least $3 million from Sunrise Pharmaceutical, plus statute-imposed, mandatory treble damages and attorney fees pursuant to NJ Stat. Ann. § 56:8-19, stemming from Sunrise Pharmaceutical's defective manufacture of certain drug products deemed adulterated and unsalable by the U.S. Food & Drug Administration (FDA) as well as Sunrise Pharmaceutical's willful sale of said adulterated drugs to Vision Pharma without notice of the FDA's investigations and determinations. The case is styled Vision Pharma, LLC v. Sunrise Pharmaceutical Inc., C.A. No. 2:13-cv-04692-CCC-JAD and is now pending before the Hon. Claire C. Cecchi.
A full list of the nine (9) causes of action asserted by Vision Pharma upon which it seeks relief from the U.S. District Court is as follows:
Count 1: Violation of New Jersey Consumer Fraud Act
Count 2: Breach of Contract
Count 3: Willful Breach of Implied Warranty of Merchantability
Count 4: Breach of Implied Warranty of Fitness for a Particular Purpose
Count 5: Breach of Covenant of Good Faith and Fair Dealing
Count 6: Unjust Enrichment
Count 7: Negligence
Count 8: Deceptive Trade Practices
Count 9: Fraud & Deceit
"It is very unfortunate that we had to file suit against Sunrise Pharmaceutical after numerous attempts to resolve these issues amicably; however, the severe damage they caused our company left this as the only option. We are certainly prepared for a trial by jury and taking this case to the end for a well-deserved victory," said Sander S. Busman, Founder, President & CEO, Vision Pharma. Vision Pharma is being represented by lead counsel Cameron S. Reuber, Esq. and a team of attorneys at Leason Ellis LLP.
About Vision Pharma
Vision Pharma specializes in niche, generic pharmaceuticals with various delivery options and dosage forms. The company provides quality products at competitive prices while improving the lives of those who take their medicines. The organization's customer service acts promptly to requests while continuously improving to fulfill each customer and patient need. Maintaining additional inventory ensures Vision's ability to provide increased service levels. The pipeline of generic pharmaceuticals planned to market continues to be a strong focus internally and with other pharmaceutical organizations, domestically and internationally. Valuable relationships that are built show true dedication to each partnering company. You can count on Vision Pharma to consider the patient's safety as a top priority when developing and manufacturing their items. To learn more, please visit www.visionpharma.com.
Media Relations Contact:
Sander S. Busman
Founder, President & CEO
SOURCE Vision Pharma